第7章 主要国市場

第8章 抗嘔吐薬市場：R&Dパイプライン

第9章 世界の抗嘔吐薬市場：産業動向

世界の抗嘔吐薬市場のSWOT分析

強み

弱み

機会

脅威

世界の抗嘔吐薬市場のSTEP分析

第10章 調査インタビュー

第11章 結論

世界の抗嘔吐薬市場：現況

世界の抗嘔吐薬市場の展望

図表

目次

Treatments for nausea and vomiting - explore business trends, R&D, and revenue forecasts

What's the future of treating nausea and vomiting? For those medicines you get
sales predictions, also exploring research and development. Those treatments
hold high potential. There you assess results, progress, therapies, and
opportunities.

Visiongain's new report forecasts those revenues to 2024 at overall world
market, submarket, product, and national level. Discover business potentials -
trends, technologies, and new drugs.

Read on to explore anti-nausea and anti-vomiting therapies, seeing their
potential revenue.

Forecasts to 2024 and other analyses explain and predict that pharma market

Also you explore research and development (R&D). That study gives 41 tables,
48 charts, and an interview with a company. There find how you could benefit
your authority and save time, staying ahead.

That study lets you assess the future of treating nausea and vomiting -
especially in cancer treatment - exploring rising needs and demands. You find
where opportunities and money lie. See, from 2014, where best selling
prospects exist.

And the following sections show how that new investigation benefits your
research, analyses and decisions.

Forecasting of that world market and its main segments

In our report you discover overall world revenue to 2024 for antiemetic
medicines, with discussions.

You also find individual revenue predictions to 2024 for four submarkets at
world level - drug classes:

5-HT3 antagonists

Cannabinoids

Dopamine antagonists

Other agents (grouped).

There you assess outlooks for expansion in trade, hearing where you could
gain. That work investigates therapies, uses, and rising sales. Our study also
explores competition.

There you hear what's happening for developers, producers, and sellers of
antiemetic agents, understanding challenges, trends, and rising sales.

That work also splits its overall world market into products.

Predictions of leading treatments' sales

How will drugs perform to 2024 at world level? Our study forecasts individual
revenues of eight top products:

Palonosetron

Ondansetron

Granisetron

Dolasetron

Dronabinol

Nabilone

Metoclopramide

Domperidone.

There you find medicines and years with highest predicted sales. You also
examine competitors. See, then, what's happening, understanding, challenges,
trends, and outlooks.

The new study also gives geographical revenue predictions.

Healthcare in national markets - what outlooks for that business?

In developed and developing countries, many opportunities for developers,
producers, and sellers of antiemetic medicines will occur from 2014 to 2024.
See where and how.

Our analyses show individual revenue forecasts to 2024 for 11 national markets:

The report also explains issues, forces, and events affecting the antiemetic
drugs industry and market from 2014, including these:

Emesis and its pharmacological management - pathways and targets

Future of serotonin (5-HT3) antagonists - existing and new therapies

Demand for antiemetics in post-operative settings, inc. cancer and other
diseases

Drug delivery to improve patient compliance.

And you assess these trends and influences, among others:

Improvements in design of clinical trials for those treatments

Effects of investments in healthcare, esp. in emerging countries

Improvements to therapy, inc. using antihistamines and prolonging drug
action

Efforts to develop new drugs - R&D harnessing new receptors and mechanisms
of action, with emerging technologies.

There you explore political, economic, social, and technological questions, as
well as strengths weaknesses, opportunities, and threats. Discover what the
future holds. See, too, how R&D helps companies benefit patients and expand
that market.

You find, then, what stimulates and restrains firms in that sector, affecting
its results.

Antiemetic medicines - opportunities and 2018 market value

Our study predicts that overall world market will reach $4.6bn in 2018, with
further expansion to 2024.

There large pharmaceutical corporations and specialty companies can gain. See
how.

From 2014 to 2024 that industry holds many opportunities. And you examine its
technological and commercial possibilities, staying ahead in knowledge.

Our work gives independent analysis. There you receive business intelligence
found only in our report, seeing where prospects are most rewarding.

With that investigation you're less likely to fall behind in information or
miss opportunity. See there how you can choose to benefit your searches,
analyses and decisions, also saving time and helping your influence.

Our new study is for everyone analysing medications for nausea and vomiting.
There you find data, trends, opportunities and sales predictions. Please get
that report here now.

Visiongain is a trading partner with the US Federal Government.

Table of Contents

1. Overview of Report

1.1. Antiemetic Drug Treatments: World Market Review

1.2. Content of Report Chapters

1.3. Research and Analysis Methods

2. Introduction to Emesis and Antiemetic Drugs

2.1. What is Emesis?

2.1.1. The Process of Emesis: The Role of the Vomiting Centre

2.2. Causes and Complications of Vomiting Vary

2.2.1. Most Common Triggers of Vomiting

2.3. Diagnosing Emesis: Multidisciplinary Approach Required

2.4. Treating Emesis and the Approach to Pharmacological Management

2.4.1. Serotonin (5-HT3) Antagonists: Gold Standard Treatment

2.4.2. Cannabinoids: Controversial Choice, But Interest Remains

2.4.3. Dopamine Antagonists: Effective in Post-Operative Setting

2.4.4. Other Therapies

3. The Global Antiemetic Drug Market, 2014-2024

3.1. The Global Antiemetic Drug Market, 2013

3.1.1. Leading Antiemetic Drugs, 2013

3.2. The Global Antiemetic Drug Market: Revenue Forecast, 2014-2024

3.2.1. What Will Drive The Global Antiemetic Drug Market Between 2014
and 2024?